Sorrento Therapeutics
SRNEQ
$0.03000
Share price
3.45%
Change (1 day)
-85.00%
Change (1 year)
Categories
Sorrento Therapeutics (SRNEQ) - Cash on Hand
Cash on Hand as of June 2023 : $80.63 M
According to Sorrento Therapeutics
's latest financial reports the company has $80.63 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Sorrento Therapeutics - Cash on Hand chart (from 2007 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $49.97 M | -60.61% |
| 2021-12-31 | $0.12 B | 124.71% |
| 2020-12-31 | $56.46 M | 150.72% |
| 2019-12-31 | $22.52 M | -85.81% |
| 2018-12-31 | $0.15 B | 660.6% |
| 2017-12-31 | $20.87 M | -75.01% |
| 2016-12-31 | $83.5 M | -38.78% |
| 2015-12-31 | $0.13 B | 89.71% |
| 2014-12-31 | $71.9 M | 127.06% |
| 2013-12-31 | $31.66 M | 521.98% |
| 2012-12-31 | $5.09 M | 46.87% |
| 2011-12-31 | $3.46 M | -34.32% |
| 2010-12-31 | $5.27 M | 53.87% |
| 2009-12-31 | $3.42 M | |
| 2008-12-31 | $N/A | -100% |
| 2007-12-31 | $0.02 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Karyopharm Therapeutics
KPTI | $0.19 B | 137.42% | 🇺🇸 USA |
 Exelixis EXEL | $0.96 B | 1,094.59% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | N/A | N/A | 🇺🇸 USA |